Profile picture

Doctor Matteo Beltrami

Careggi, Florence (Italy)
Membership: ESC Professional Member
Follow
Biography
I was born in Siena and I obtained my medical degree at University of Siena. I completed my 5-years training with fellowships in cardiology at the University of Florence. During the postgraduate program I worked as a research fellow at the Cardiomyopathy Unit, University of Florence focusing my studies in Cardiomyopathies and Heart Failure. During my career i spend a training period in Bristol Heart Institute and in CNR, University of Pisa, improving my skills in Heart Failure and Cardiac Magnetic Resonance. I have completed my PhD program on genetics, oncology and clinical medicine at the University of Siena (20/12/2020). I’m working full time as cardiologist at Careggi University Hospital in Florence with duties in Heart Failure, device therapy and Cardiomyopathies outpatient program. I’m working in collaboration with the University of Florence with Prof Iacopo Olivotto at the Cardiomyopathy Unit (Tuscany referral Center for Cardiomyopathies).
Logo ESC

Contributor content

An unexpected cause of asymmetric left ventricular hypertrophy
Presentation
An unexpected cause of asymmetric left ventricular hypertrophy
Unveiling a rare genotype in apparent HCM classic phenotype
Presentation
Unveiling a rare genotype in apparent HCM classic phenotype
The role of fibrosis and inflammation for response and outcome prediction in candidates to cardiac resynchronization therapy: is response the right answer?
Presentation
The role of fibrosis and inflammation for response and outcome prediction in candidates to cardiac resynchronization therapy: is response the right answer?
Relation of QRS duration to response to cardiac resynchronization therapy in patients with left bundle branch block
Presentation
Relation of QRS duration to response to cardiac resynchronization therapy in patients with left bundle branch block
Multi-biomarkers laboratory strategy  for outcome prediction in patients with severe systolic dysfunction submitted to CRT
Presentation
Multi-biomarkers laboratory strategy for outcome prediction in patients with severe systolic dysfunction submitted to CRT
Dynamic variation of renal function and novel or old HF biomarkers (ST2, Galectin 3, NT-proBNP) and response to cardiac resynchronization therapy (CRT)
Presentation
Dynamic variation of renal function and novel or old HF biomarkers (ST2, Galectin 3, NT-proBNP) and response to cardiac resynchronization therapy (CRT)
Additional value of Galectin-3 respect to BNP in acute heart failure patients with preserved ejection fraction
Presentation
Additional value of Galectin-3 respect to BNP in acute heart failure patients with preserved ejection fraction

ESC 365 is supported by